Skip to content

James Pritchett

  • BSc (Hons) PhD
  • Lecturer
  • Manchester Metropolitan University School of Healthcare Science
  • 7h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 261CitationsNumber of citations received by James's publications. Updated daily.

Recent publications

  • SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis

    • Athwal V
    • Pritchett J
    • Llewellyn J
    • et al.
    N/AReaders
    7Citations
  • Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells

    • Pritchett J
    • Athwal V
    • Harvey E
    • et al.
    N/AReaders
    9Citations

Professional experience

Lecturer

Manchester Metropolitan University School of Healthcare Science

February 2017 - Present

Honorary Lecturer

University of Manchester Centre for Endocrinology and Diabetes

February 2017 - Present

Post Doctoral Research Associate

School of Biomedicine, University of Manchester

May 2009 - January 2017(8 years)

Visiting Post Doctoral Fellow

Liver Research Laboratory, Mount Sinai Hospital, New York

January 2012 - May 2012(4 months)

Postdoctoral Research Associate

Cardiovascular Research Group, University of Manchester

October 2006 - April 2009(3 years)

Associate Scientist

AstraZeneca Pharmaceuticals

November 2002 - August 2003(9 months)

Placement Student

GlaxoSmithKline

September 2000 - August 2001(a year)

Education

PhD

Faculty of Life Sciences, University of Manchester

September 2003 - September 2006(3 years)

BSc (Hons), Biochemistry (with industry)

Faculty of Biological Sciences, University of Leeds

September 1998 - August 2002(4 years)

Co-authors (58)

  • J Humphries
  • Dr. Brendan Keegan
  • Richard Stephens
  • Hugh Rice
  • Nicholas Hylton
  • Adam Byron